Please login to the form below

Not currently logged in
Email:
Password:

Sir Tom Blundell to remain as chair of UK’s biotech research council

Reappointed to government role to support research

BBSRC Sir Tom BlundellSir Tom Blundell has been reappointed as chair of the UK's Biotechnology and Biological Sciences Research Council (BBSRC), a government-funded organisation to support research in the UK.

This is Sir Tom's second term in the position, having originally been appointed to the role in July 2009. He will now serve a further two years more than his original four-year term, with his reappointment lasting until June 30, 2015.

He was also one of the initial founders of the BBSRC in 1994, serving for two years as its chief executive.

“I am delighted that Sir Tom Blundell has agreed to remain as chair of BBSRC,” said David Willetts, minister for universities and science.

“His extensive academic experience in the field of biochemistry coupled with his active role in science policy makes him an invaluable asset to the council.”

This experience includes Sir Tom's current role as professor emeritus and director of research in biochemistry at the University of Cambridge. 

He was previously head of the School of Biological Sciences in Cambridge and Sir William Dunn Professor of Biochemistry.

Sir Tom has prior experience in science policy, serving as a member of the advisory group to the Prime Minister in the 1980s.

He has also spent time as chairman of the Royal Commission on Environmental Pollution, president of the UK Biosciences Federation and president of UK Science Council.

In addition to his academic and policy background, Sir Tom has industry experience, serving as non-executive director of biotech Celltech from 1996 to 2005 and holding advisory roles with Pfizer, UCB and SmithKline Beecham (now part of GSK).

27th February 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics